Disposable Endoscope Market: Market Size & Forecast 2026

Disposable endoscopes are single-use versions of devices such as bronchoscopes, gastroscopes, ureteroscopes, duodenoscopes, laryngoscopes, and rhinolaryngoscopes, used for diagnostic and therapeutic procedures in the respiratory, gastrointestinal, and urological systems. The market was worth approximately $4.1 billion in 2025 and is projected to more than triple over the next decade, reaching between $12 billion and $13.3 billion by the mid-2030s depending on the forecast horizon. North America currently represents the largest regional market, followed by Europe, while Asia-Pacific is the fastest-growing region due to expanding healthcare access and rising procedure volumes.

• •Estimated 2025 market value: ~$4.1 billion, with a compound annual growth rate near 16.8%.
• •Forecast range for 2034-2035: roughly $12-$13.3 billion across published projections.
• •North America leads today; Asia-Pacific is the fastest-growing regional segment.

The most significant growth driver is the rising emphasis on infection control following well-documented outbreaks of multidrug-resistant organisms linked to contaminated reusable duodenoscopes and bronchoscopes. Regulatory bodies such as the U.S. FDA have pushed manufacturers toward single-use designs, particularly for high-risk devices, while hospitals seek to avoid the operational complexity and liability of reprocessing. Demand is also being lifted by an increasing volume of endoscopic procedures, especially in aging populations with higher rates of gastrointestinal, pulmonary, and urological disease.

• •Heightened focus on preventing cross-contamination and healthcare-associated infections.
• •FDA guidance favoring single-use duodenoscopes and similar high-risk devices.
• •Aging populations and rising procedural volumes in respiratory, GI, and urology care.

By product type, the market is segmented into bronchoscopes, gastrointestinal endoscopes (including gastroscopes and colonoscopes), ureteroscopes, duodenoscopes, laryngoscopes, and rhinolaryngoscopes, with bronchoscopes and GI scopes historically representing the largest share. By end user, hospitals account for the majority of demand, followed by ambulatory surgical centers and specialty clinics. Geographically, North America holds the leading share due to early technology adoption and clear reimbursement pathways, while Europe represents a mature second market, and Asia-Pacific, Latin America, and the Middle East are emerging growth regions.

• •Bronchoscopes and gastrointestinal endoscopes lead the product mix; duodenoscopes are a focal growth segment.
• •Hospitals are the dominant end user, with ambulatory surgical centers expanding rapidly.
• •Asia-Pacific is projected to post the fastest regional CAGR through 2034-2035.

What are the recent trends and outlook?

The clearest trend is the gradual migration from reusable to single-use platforms in higher-risk procedure categories, particularly duodenoscopy, bronchoscopy, and ureteroscopy, where contamination risk has been hardest to control. Manufacturers are investing in improved chip-on-tip imaging, better articulation, AI-assisted visualization, and ergonomic handle design to close the performance gap with reusable scopes. Looking ahead, the market is expected to sustain mid-to-high teens annual growth through 2035, supported by hospital procurement shifts, expanded indications, and the growing availability of clinically validated single-use devices across most endoscopic specialties.

• •Rapid category-by-category shift from reusable to single-use, starting with duodenoscopes and bronchoscopes.
• •Technology focus areas: high-definition imaging, better tip articulation, and AI-enabled lesion detection.
• •Sustained ~15-17% CAGR expected through 2034-2035 as clinical adoption broadens.